ArticleScientific reports2026
A handheld near infrared scanner for the detection of acute traumatic intracranial hemorrhage.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The Archeoptix NIRD device is a handheld near infrared scanner for intracranial hemorrhage of at least 3 mL in volume located up to 3.5 cm from the scalp. It generates an image that approximates hemorrhage location on a schematic head. We report a prospectively collected cohort of scans from patients with traumatic brain injury and CT-confirmed intracranial hemorrhage, alongside healthy control subjects, to evaluate the utility and accuracy of this technology. Patients with hemorrhage were recruited from the neurosurgical service within 24 h of trauma for a single scan, and also controls with no history of head trauma or neurological symptoms. Blinded reviewers judged each scan for presence or absence of hemorrhage and whether hemorrhage position matched CT. Thirty-seven patients with hemorrhage and 40 controls were scanned. Reviewers identified hemorrhage in 37/37 patients and no hemorrhage in 40/40 controls, with correct localization in 35/37 scans. Repeat passes were sometimes required for user-induced errors from external light exposure or loss of detector contact, occurring more often in hemorrhage cases and modestly increasing time to complete subsequent paths. The Archeoptix NIRD device shows promise as a point-of-care or remote diagnostic tool, and further work can fully establish sensitivity, specificity, and user experience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.